You are viewing a single comment's thread.

view the rest of the comments →

0
3

[–] mac1221 0 points 3 points (+3|-0) ago  (edited ago)

Awesome digs anon. Much thanks for your efforts.

Not that is means anything, but I just find it curious that it is a HIV genome sequencing that allowed a horseshoe bat coronavirus to cross species. Several labs are connected with SARS and MERS. Gates and Pirbright have patents on animal coronaviruses. Fauci is connected with HIV. Hmmm...mucho money flowing.

"Inovio Pharmaceuticals has announced a grant of up to $9 million from the Coalition for Epidemic Preparedness Innovations to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV) that to date has killed more than a hundred people in China and infected hundreds more.

The initial funding from CEPI will support preclinical and Phase 1 clinical development of INO-4800, the company's new coronavirus vaccine candidate. CEPI previously awarded Inovio grants of up to $56 million for the development of vaccines against Lassa fever and Middle East Respiratory Syndrome (MERS), which is also caused by a coronavirus.

Launched in Davos in 2017 to develop vaccines for emerging infectious diseases, CEPI is a public-private partnership that has received multiyear funding from Norway, Germany, Japan, Canada, and Australia, as well as from the Bill & Melinda Gates Foundation and the Wellcome Trust. To date, the partnership has committed more than $310 million for the development of twelve vaccine candidates (five targeting Lassa virus, four targeting MERS-CoV, and three targeting Nipah virus) as well as two rapid response vaccine platforms."

https://philanthropynewsdigest.org/news/inovio-receives-up-to-9-million-to-develop-coronavirus-vaccine

Inovio is linked to Prepvacc which is a new African-led, European-supported HIV prevention study running in East and Southern Africa from 2018 to 2023. Same list of characters - PEPFAR (Fauci, Birx, and Pence), Inovio (vaccine maker), the Wellcome Trust and the Bill and Melinda Gates Foundation. Check out some of the other funders.

"For the first time, it is combining evaluation of experimental HIV vaccines and pre-exposure prophylaxis (PrEP) at the same time.

PrEPVacc is a public-private partnership. The European & Developing Countries Clinical Trials Partnership (EDCTP) awarded a grant of €15M for the study and all of the institutional partners are providing co-funding through staff salaries. Gilead Inc and Inovio Pharmaceuticals are giving support to the project through materials and medicines. PrEPVacc is also supported by USAID and PEPFAR, USMHRP, SVRI, SAMRC, UKRI, the Wellcome Trust and the Bill and Melinda Gates Foundation."

https://www.prepvacc.org/funders